Explore
Validate
Learn10707-1-AP
antibody from Proteintech Group
Targeting: CXCL11
b-R1, H174, I-TAC, IP-9, SCYB11, SCYB9B
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10707-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10707-1-AP, RRID:AB_2088022
- Product name
- CXCL11 antibody
- Antibody type
- Polyclonal
- Description
- CXCL11 antibody (Cat. #10707-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Inhibiting ADAR1-Mediated Excessive Epigenetic A-to-I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma.
Rab32-mediated macrophage apoptosis and apoptotic body release promote M1 polarization in ARDS via the Cxcl11/Ccl4/NF-κB pathway.
Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11.
CRTC1 enhances PD-L1-mediated tumor immunosuppression in non-small cell lung cancer via the Notch1/Akt signaling pathway.
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.
Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto's Thyroiditis by Comprehensive Analysis.
Silent information regulator 1 ameliorates oxidative stress injury via PGC-1α/PPARγ-Nrf2 pathway after ischemic stroke in rat.
Wang S, Zheng S, Liu C, Zhang C, Wang X, Wang Z, Wang Y, Feng X, Xue Q, Sun N, He J
MedComm 2026 Mar;7(3):e70574
MedComm 2026 Mar;7(3):e70574
Rab32-mediated macrophage apoptosis and apoptotic body release promote M1 polarization in ARDS via the Cxcl11/Ccl4/NF-κB pathway.
Wu D, Liu Q, Zhou X, Zhang R, Qian H, He B, Wang D
International immunopharmacology 2026 Apr 15;175:116431
International immunopharmacology 2026 Apr 15;175:116431
Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11.
Zhang H, Xu B, Yin M, Dong Y, Lu M
Open life sciences 2025;20(1):20251147
Open life sciences 2025;20(1):20251147
CRTC1 enhances PD-L1-mediated tumor immunosuppression in non-small cell lung cancer via the Notch1/Akt signaling pathway.
Feng X, Shi Y, Yuan F, Hu Y, Tang X, Zhang W, Gan J, Sun L, Cao L
Frontiers in immunology 2025;16:1658679
Frontiers in immunology 2025;16:1658679
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.
Li HS, Tang R, Shi HS, Qin ZJ, Zhang XY, Sun YF, Wei ZG, Ma CF, Yang L, Chen Y, Liu ZR, Zhu LL, Yang W, Yang L, Xu AN, Zhang Z, Liao SQ, Shi JS, Deng JJ, He XZ, Peng XC
Signal transduction and targeted therapy 2025 Mar 3;10(1):82
Signal transduction and targeted therapy 2025 Mar 3;10(1):82
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype.
Xu X, Qiu T, Sun K, Han X, Huang J, Wang X, Ge J, Yang J
Arthritis research & therapy 2025 Feb 8;27(1):26
Arthritis research & therapy 2025 Feb 8;27(1):26
Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer.
Nie H, Yu Y, Wang F, Huang X, Wang H, Wang J, Tao M, Ning Y, Zhou J, Zhao Q, Xu F, Fang J
Cancer immunology, immunotherapy : CII 2024 Jun 4;73(8):156
Cancer immunology, immunotherapy : CII 2024 Jun 4;73(8):156
Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto's Thyroiditis by Comprehensive Analysis.
Xi Z, Yang T, Huang T, Zhou J, Yang P
Biomedicines 2023 Nov 24;11(12)
Biomedicines 2023 Nov 24;11(12)
Silent information regulator 1 ameliorates oxidative stress injury via PGC-1α/PPARγ-Nrf2 pathway after ischemic stroke in rat.
Zhou Y, Peng L, Li Y, Zhao Y
Brain research bulletin 2022 Jan;178:37-48
Brain research bulletin 2022 Jan;178:37-48
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CXCL11 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CXCL11. This antibody recognizes human antigen. The CXCL11 antibody has been validated for the following applications: ELISA, WB analysis.
